The 6th Frederick E. Hargreave Lectureship

St. Joseph's Hospital, Juravinski Tower, Level 2, Miller Aphitheatre

05/11/2018, 5:00 pm - TO 05/11/2018 - 7:00 pm

Organizer: Department of Medicine/Firestone Institute for Respiratory Health

My Calendar

The Department of Medicine and the Divisions of Respirology and Allergy & Clinical Immunology are pleased to announce the 6th Frederick E. Hargreave Lectureship in Asthma and Allergy to honour the memory of our dear colleague, who passed away on the 15th of June, 2011. Professor Freddy Hargreave was one of the giants of respiratory medicine. His work helped change the way we understand, diagnose and treat asthma, bronchitis and COPD. In doing so, he significantly improved the care of patients throughout the world and his work improved many lives. At the Firestone Clinic, over a 40 year career, he taught many students and fellows from all over the world, many of whom returned home and became internationally recognized in their own right. He made St Joseph’s Hospital and the Firestone Clinic world famous, but more importantly, he cared for individual patients in an exemplary manner with unfailing courtesy, dedication, humility, and kindness. He constantly endeavored to bring the health challenges his patients faced every day to the research community in order to find better ways to improve the quality of their lives.

The 2018 Lecture will be delivered by Dr Chris Brightling. Dr Brightling is a Professor of Medicine at the University of Leicester, National Institute for Health Research Senior Investigator, former Wellcome Trust Senior Clinical Fellow, and an Honorary Consultant Respiratory Physician at the Institute for Lung Health, Leicester, UK. He is the Clinical Interventions Theme Lead for the Leicester NIHR Respiratory Biomedical Unit and a Coordinator for the European Union Consortium AirPROM, MRC/ABPI COPD (COPDMAP) Consortium and the MRC Molecular Pathology Node EMBER. As a well-respected expert in the immunopathogenesis of airway diseases, particularly asthma, chronic cough and COPD, his current projects include understanding the interactions between mast cells and airway smooth muscle cells in the development of the asthmatic phenotype, and migration and remodeling of airway smooth muscle in asthma and COPD. Professor Brightling has published over 300 peer-reviewed articles and has an h-index of 69. He has contributed to updates for the American College of Chest Physicians’ Cough Guidelines, the British Thoracic Society Difficult Asthma Guidelines, the World Health Organization Severe Asthma Strategy and the American Thoracic Society/European Respiratory Society Severe Asthma Task Force.

Registration and  RSVP is not required.